We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App


ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

44th IHF World Hospital Congress Presents Over 60 Plenary Sessions and 200 Renowned Speakers Across Four-Day Event

By HospiMedica International staff writers
Posted on 17 Sep 2021
Print article
The 44th World Hospital Congress organized by The International Hospital Federation (Geneva, Switzerland) will bring together more than 200 healthcare experts, leading industry thinkers, and best practice presenters at over 60 sessions around nursing leadership, humanizing technology, COVID-19 vaccination, the next global pandemic, etc.

The 2021 World Hospital Congress is set to take place on 8-11 November in Barcelona, Spain and will be one of the first hybrid healthcare management events that will take place in Europe in 2021. Offering a compelling mix of sessions, posters, IHF Awards, hospital visits, networking opportunities, social activities, and an industry exhibition, the event will provide a comprehensive experience. And for those unable to travel, virtual access is available. All sessions will be live-streamed in a dedicated event platform and recordings will be made available to all attendees for on-demand viewing.

With the overarching theme "People on board: Transforming healthcare by blending agility, responsiveness, and resilience", the 44th World Hospital Congress will present over 60 sessions where more than 200 renowned speakers will gather to share their knowledge and good practices on healthcare transformations enacted across the globe. Among several sessions across the four-day event, the more thought-provoking ones include “Getting ready for the next global pandemic: European and North American perspectives” in which public health leaders from Europe and North America will share their views on how the next pandemic might unfold; how they are leading their organizations to address the next pandemic with the lessons learned from COVID-19; and the changes needed in their organizations and local health systems to effectively respond to the next public health crisis.

The speakers at this plenary session will include Dr. Rod Hochman, M.D., president and CEO of Providence; Dr. Natasha Azzopardi-Muscat, Director of the Division of Country Health Policies and Systems at WHO Regional Office for Europe and Associate Professor at the University of Malta; Dr. JM. Campistol, nephrologist and current General Director of the Hospital Clínic de Barcelona; Dr. Bechara Choucair, MD, White House COVID-19 Vaccinations Coordinator; Wright L. Lassiter III, President and CEO of Henry Ford Health System; and Bertrand Levrat, CEO of the University Hospitals of Geneva (HUG), the largest university hospital in Switzerland.

Another thought-provoking plenary session “Accelerating research, development and distribution of the COVID-19 vaccine: Lessons learned from key stakeholders” will focus on ways to accelerate translational research, transform the way vaccines are developed and distributed and utilize new partnerships and collaborations from industry, governments and global public health actors. This session will also explore the drivers and constrains for such an agile and good response to the crisis, as well as the key learnings that can be gleaned from the different stakeholders for the near future. The session will be chaired by Dr. Hans Kluge, Regional Director for Europe, World Health Organization and will also include other participants such as Dr. Carmen Cabezas, Secretary of Public Health at Department of Health of the Generalitat de Catalunya, Spain; Thomas Cueni, Director General at International Federation of Pharmaceutical Manufacturers & Associations; Dr. César Hernández, Head of Department of Medicines for Human Use at Spanish Agency for Medicines and Medical Devices, Spain; and Dr. John Nkengasong, Director at Africa Centers for Disease Control and Prevention, Ethiopia.

Related Links:
The International Hospital Federation

Gold Supplier
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gynecological Examination & Treatment Chair
Hydraulic Surgeon's Chair/Stool
Dose Area Product Measuring System
VacuDAP duo

Print article
FIME - Informa



view channel
Image: The AI tool can also tackle dangerous inequalities in heart attack diagnosis (Photo courtesy of Freepik)

AI Algorithm Integrates Cardiac Troponin Test Results with Clinical Data to Quickly Rule out Heart Attacks in Patients

The accepted standard for diagnosing myocardial infarction, or heart attack, involves assessing the blood for troponin levels. However, this approach applies the same benchmark for all patients, failing... Read more

Critical Care

view channel
Image: Electromagnetic cores precisely guide the array of nanozyme-bots as they target the site of fungal infection (Photo courtesy of University of Pennsylvania)

Nanorobots Guided by Magnets Capable of Rapid, Targeted Elimination of Fungal Pathogens

Fungal infections, particularly those caused by Candida albicans, present a significant health threat globally due to their resistance to current treatments. Although nanomaterials show potential as antifungal... Read more

Surgical Techniques

view channel
Image: The benchmark may be useful in identifying the best treatment hospital for patients with gallbladder cancer (Photo courtesy of Freepik)

First-Ever Standard for Gallbladder Cancer Surgery Could Improve Patient Outcomes

Gallbladder cancer (GBC) surgery is a technically demanding procedure that requires significant expertise to meet high-quality surgical standards. Despite this, subpar surgeries are common, highlighting... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: IntelliSep is the first FDA-cleared diagnostic tool to assess cellular host response to aid in identifying ED patients with sepsis (Photo courtesy of Cytovale)

Rapid Microfluidic Test Demonstrates Efficacy as Diagnostic Aid to Improve Sepsis Triage in ED

Sepsis is the primary cause of mortality worldwide, accounting for over 350,000 fatalities annually in the United States alone, a figure that surpasses deaths from opioid overdoses, prostate cancer, and... Read more
Copyright © 2000-2023 Globetech Media. All rights reserved.